MERGER INVESTIGATION ALERT: The Law Offices of Vincent Wong Notify Investors of an Investigation into the Fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger
NEW YORK, May 22, 2023 /PRNewswire/ -- Attention NRx Pharmaceuticals Inc. (f/k/a Big Rock Partners Acquisition Corp.) ("NRXP" or the "Company") (NASDAQ: NRXP) investors who purchased stock prior to May 24, 2021 and still hold such stock:
An investigation has been commenced into the fairness of NRXP's 2021 de-SPAC merger. Shortly after the NRXP 2021 de-SPAC merger closed, NRXP stock began spiraling downwards.
The Law Offices of Vincent Wong's investigation concerns whether this transaction unfairly harmed stockholders and whether all material facts were properly disclosed to stockholders.
If you are a current NRXP shareholder, contact us for more information by using the link below. There is no cost or obligation to you.
https://www.wongesq.com/mergeracquisition/nrx-pharmaceuticals-merger-investigation-form
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: [email protected]
SOURCE The Law Offices of Vincent Wong
Share this article